Last reviewed · How we verify
NCT07343856: EAV-LONGCOVID
Long COVID Diagnostic Reactivity Assesment Test
NA trial testing Electrodiagnostic Bioelectrical Assessment in Long COVID in 50 participants. Enrolling by invitation.
30 December 2026
Quick facts
| Lead sponsor | Oncology Center,Ministry Of Heath,Uzbekistan |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 5 December 2025 |
| Primary completion | 30 December 2026 |
| Estimated completion | 1 January 2027 |
| Sites | 1 location across Uzbekistan |
Drugs / interventions tested
- Electrodiagnostic Bioelectrical Assessment
Conditions studied
- Long COVID — all drugs for Long COVID →
- Post-Acute Sequelae of SARS-CoV-2 Infection — all drugs for Post-Acute Sequelae of SARS-CoV-2 Infection →
Sponsor
Oncology Center,Ministry Of Heath,Uzbekistan
Who can join
Adults 18 to 75, any sex, with Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07343856
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Long COVID
Currently open trials in the same condition.
- NCT05931497 — Sauna for Long Covid · NA · recruiting
- NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
Other Oncology Center,Ministry Of Heath,Uzbekistan trials
Trials by the same sponsor.
- NCT07325682 — Diagnostic Evaluation of Viral Persistence in Cervical Cancer · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07343856 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oncology Center,Ministry Of Heath,Uzbekistan
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07343856.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing